Vonoprazan
Overview[edit | edit source]
Vonoprazan is a medication that belongs to a class of drugs known as potassium-competitive acid blockers (P-CABs). It is primarily used for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease. Unlike traditional proton pump inhibitors (PPIs), vonoprazan works by competitively blocking the potassium-binding site of the H+/K+ ATPase enzyme in the stomach lining, leading to a reduction in gastric acid secretion.
Mechanism of Action[edit | edit source]
Vonoprazan acts by inhibiting the H+/K+ ATPase enzyme, which is responsible for the final step in the production of gastric acid in the stomach. By blocking the potassium-binding site of this enzyme, vonoprazan effectively reduces the secretion of gastric acid, providing relief from acid-related disorders.
Clinical Uses[edit | edit source]
Vonoprazan is used in the management of several acid-related gastrointestinal conditions, including:
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Helicobacter pylori eradication therapy, often in combination with antibiotics
Advantages over Proton Pump Inhibitors[edit | edit source]
One of the main advantages of vonoprazan over traditional PPIs is its rapid onset of action. Vonoprazan begins to reduce gastric acid secretion more quickly than PPIs, which require activation in the acidic environment of the stomach. This rapid action can lead to faster symptom relief for patients.
Additionally, vonoprazan is less affected by genetic variations in CYP2C19, an enzyme that metabolizes many PPIs, leading to more consistent therapeutic effects across different patient populations.
Side Effects[edit | edit source]
Common side effects of vonoprazan may include:
Serious side effects are rare but can include hypomagnesemia and Clostridium difficile infection.
Pharmacokinetics[edit | edit source]
Vonoprazan is well absorbed after oral administration and has a long half-life, allowing for once-daily dosing. It is metabolized in the liver and excreted primarily in the urine.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
